Department of Infectious Diseases, Shanghai Public Health Clinical Center, Shanghai, China.
Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi, Jiangnan University, Wuxi, China.
Biosci Trends. 2021 Jul 6;15(3):192-195. doi: 10.5582/bst.2021.01242. Epub 2021 Jun 26.
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a serious public health burden. As the COVID-19 epidemic in China would coincide with a seasonal outbreak of influenza, there were serious concerns about whether influenza would be aggravated by the SARS-CoV-2 infection and COVID-19 pandemic. This article provides a brief overview of the impacts of the COVID-19 epidemic on influenza activity in China. The percentage of positive influenza tests decreased during the COVID-19 pandemic. During the first stage of the COVID-19 outbreak, the percentage of positive influenza tests reached to a peak of 47.7%. At the second stage, the percentage of positive influenza tests was dramatically decreased from 40.4% to 14.0%. Thereafter, it remains at a low level of less than 6.2%. In addition, the possible causes of this phenomenon have been summarized, including prevention and control measures and ecological competition. Lastly, this article suggests that the public health approach to preventing COVID-19 may also help to control other respiratory infectious diseases. Public health measures need to be maintained even in the later stages of the COVID-19 epidemic.
由严重急性呼吸系统综合症冠状病毒 2 型(SARS-CoV-2)引起的 COVID-19 大流行对公众健康造成了严重负担。由于中国的 COVID-19 疫情将与季节性流感爆发同时发生,人们严重担心 SARS-CoV-2 感染和 COVID-19 大流行是否会加重流感。本文简要概述了 COVID-19 疫情对中国流感活动的影响。在 COVID-19 大流行期间,流感检测阳性率下降。在 COVID-19 爆发的第一阶段,流感检测阳性率达到 47.7%的峰值。在第二阶段,流感检测阳性率从 40.4%急剧下降至 14.0%。此后,阳性率一直保持在 6.2%以下的低水平。此外,还总结了造成这种现象的可能原因,包括预防和控制措施以及生态竞争。最后,本文建议预防 COVID-19 的公共卫生措施也可能有助于控制其他呼吸道传染病。即使在 COVID-19 大流行的后期,也需要维持公共卫生措施。
Biosci Trends. 2021-7-6
Zhonghua Yu Fang Yi Xue Za Zhi. 2020-10-6
Zhonghua Yi Xue Za Zhi. 2024-2-27
J Korean Med Sci. 2020-5-18
Emerg Infect Dis. 2020-8-27
Zhonghua Yu Fang Yi Xue Za Zhi. 2022-2-6
Health Data Sci. 2022-11-1
Front Med (Lausanne). 2022-4-25